Literature DB >> 348553

Double blind study of milk lactose intolerance.

R Lisker, L Aguilar.   

Abstract

One hundred and fifty subjects were studied in a double blind fashion to determine the relationship between lactose malabsorption and milk lactose intolerance. Each participant received 250 ml of a different type of milk on 3 consecutive days. Milk A contained no lactose, milk B had 12.5 g, and milk C contained 37.5 g of lactose. After the experiment was completed each subject was classified with a lactose tolerance test as having "sufficient" or "insufficient" lactase activity. Milk A produced no gastrointestinal symptoms in either sufficient or in insufficient persons. Milk B produced symptoms in 3.8% of sufficient and 37.1% of insufficient individuals, and Milk C induced symptoms in 7.6% of sufficient and 83.5% of insufficient subjects. These differences are very highly significant (P less than 0.0001). It is concluded that lactose-intolerant subjects are indeed milk-intolerant and that the frequency with which symptoms occur in persons with lactose malabsorption increases in direct relation to the lactose content of the milk.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 348553

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  3 in total

1.  Coincidental malabsorption of lactose, fructose, and sorbitol ingested at low doses is not common in normal adults.

Authors:  S D Ladas; I Grammenos; P S Tassios; S A Raptis
Journal:  Dig Dis Sci       Date:  2000-12       Impact factor: 3.199

2.  Distribution of human adult lactase phenotypes in the population of Austria.

Authors:  W Rosenkranz; B Hadorn; W Müller; P Heinz-Erian; C Hensen; G Flatz
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

3.  Treatment of chronic portal-systemic encephalopathy with lactose in lactase-deficient patients.

Authors:  M Uribe; M A Márquez; G García-Ramos; V Escobedo; H Murillo; L Guevara; R Lisker
Journal:  Dig Dis Sci       Date:  1980-12       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.